Heart Attack News and Research

RSS

Cardiac rehab can prolong patients' lives and reduce risk of second heart attack

Twenty-eight year-old Alex Holton is an active young Torontonian, but five years ago, shortly after receiving life-saving heart surgery, Alex Holton was unsure he'd ever be active again.

28 Jul 2011

New study shows high prevalence of gout in the U.S.

A new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans.

28 Jul 2011

Britain’s prescription drug use statistics revealed

According to latest NHS figures number of prescriptions dispensed has soared by 70 per cent over the last decade. Every man, woman and child in the country received on average 17.8 prescription items in 2010. The vast majority went to those aged over 60, who received 42.4 items each in 2007.

27 Jul 2011

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that new preclinical data published in the online edition of Circulation Research suggests that microRNA-15 (miR-15) inhibits cardiomyogenesis, the process whereby new heart muscle cells are formed.

27 Jul 2011

Specific predictors can differentiate dying suddenly versus living through heart attack

Is it possible to predict whether someone is likely to survive or die suddenly from a heart attack? A new study by researchers at Wake Forest Baptist Medical Center has answered just that.

26 Jul 2011

Diabetes drug rosiglitazone can reduce development of neuropathic pain

The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

26 Jul 2011

When psoriasis strikes the famously beautiful

It appears that psoriasis spares none. Reality TV star Kim Kardashian has been reportedly diagnosed with the skin condition. Her condition was revealed on a recent episode of “Keeping Up with the Kardashians” on E!.

25 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

Researchers identify IDOL protein as potential new target for lowering LDL cholesterol

High levels of 'bad' cholesterol (LDL cholesterol) are a risk factor for developing atherosclerotic cardiovascular disease (ASCVD) - a disease of the major arterial blood vessels that is one of the major causes of heart attack and stroke.

21 Jul 2011

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

21 Jul 2011

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

21 Jul 2011

FDA approves AstraZeneca's anti-clotting drug Brilinta

The U.S. Food and drug Administration (FDA) has finally approved AstraZeneca's Brilinta blood thinner for patients with acute coronary syndrome - conditions, such as heart attack and angina.

20 Jul 2011

Stopping Aspirin may raise heart attack death risk by 60%: Study

The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.

20 Jul 2011

Ventus Medical launches Provent Sleep Apnea Therapy in India

Ventus Medical is pleased to announce the Indian launch of its proprietary Provent Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea.

20 Jul 2011

FDA seeks input on proposed oversight approach for mobile medical apps

The U.S. Food and Drug Administration today announced it is seeking input on its proposed oversight approach for certain mobile applications specific to medicine or health care called mobile medical applications that are designed for use on smartphones and other mobile computing devices.

20 Jul 2011

Married men with heart attack seek help sooner: Study

A new study implies that married men tend to live longer than their unwed counterparts, they're more likely to see their doctor regularly, and they even have a lower risk of dying from a heart attack or stroke. The study shows that men who experience chest pains while having a heart attack tend to get to a hospital sooner if they're married or in a common-law relationship. A woman's marital status, by contrast, was not associated with how quickly she sought treatment after experiencing heart-attack-related chest pains, according to the study, which was published in the Canadian Medical Association Journal.

19 Jul 2011

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced the formation of a majority owned subsidiary, NSVascular, Inc. and the signing of an exclusive license with the University of California, Los Angeles (UCLA) covering its medical applications of Thin-Film Nitinol (TFN) technology. Nitinol is a superelastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.

18 Jul 2011

Research roundup: Putting good science into practice; shifting hospital costs; finding savings in Mass.

In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.

16 Jul 2011

Provision to eliminate lifetime benefit caps in medical insurance allows life-saving heart-lung transplant

The Affordable Care Act was signed into law March 23, 2010, with the aim of extending medical coverage to more Americans. The law has been a political football, and arguments continue to rage over whether it's good or bad for the country. This, however, is simply the story of how it affected one person.

14 Jul 2011

Variation in DNA sequence linked to increased risk of sudden cardiac death

In a large and comprehensive investigation into the underlying causes of sudden cardiac death (SCD) - a surreptitious killer of hundreds of thousands annually in the United States - researchers have discovered a variation in the genome's DNA sequence that is linked to a significant increase in a person's risk of SCD.

13 Jul 2011

Heart Attack News and Research

Cardiac rehab can prolong patients' lives and reduce risk of second heart attack

New study shows high prevalence of gout in the U.S.

Britain’s prescription drug use statistics revealed

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

Specific predictors can differentiate dying suddenly versus living through heart attack

Diabetes drug rosiglitazone can reduce development of neuropathic pain

When psoriasis strikes the famously beautiful

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Researchers identify IDOL protein as potential new target for lowering LDL cholesterol

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

FDA approves AstraZeneca's anti-clotting drug Brilinta

Stopping Aspirin may raise heart attack death risk by 60%: Study

Ventus Medical launches Provent Sleep Apnea Therapy in India

FDA seeks input on proposed oversight approach for mobile medical apps

Married men with heart attack seek help sooner: Study

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

Research roundup: Putting good science into practice; shifting hospital costs; finding savings in Mass.

Provision to eliminate lifetime benefit caps in medical insurance allows life-saving heart-lung transplant

Variation in DNA sequence linked to increased risk of sudden cardiac death

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News